Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2025 09:30 ET | Source: Orbus Therapeutics, Inc.

Orbus Therapeutics Highlights Phase 3 STELLAR Clinical Study Results Showing Clinically Meaningful Benefits in Rare Brain Tumor at Society for Neuro-Oncology (SNO) Annual Meeting

– Updated results based on molecular classification and blinded independent central review demonstrate clinically meaningful survival benefits for patients with recurrent grade 3 astrocytoma who were...
September 28, 2021 10:00 ET | Source: Orbus Therapeutics, Inc.

Orbus Therapeutics Granted European Patent for Method of Use for Eflornithine

- Patent relates to method for use of eflornithine to treat cancers, including gliomas - PALO ALTO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Orbus Therapeutics Inc., a private, late-stage...